130 related articles for article (PubMed ID: 36272688)
1. Biopharmaceutical, preclinical pharmacokinetic and pharmaco-dynamic investigations of an orally administered novel 3-nbutylphthalide prodrug for ischemic stroke treatment.
Zhang Q; Han Y; Xiang H; Li M; Yang L; Liu Q; Zhang Y; Zhang Z; Lin Q; Zhang L
Eur J Pharm Sci; 2023 Jan; 180():106308. PubMed ID: 36272688
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of the neuroprotective effects of dl-3-n-butylphthalide and edaravone dexborneol on cerebral ischemic stroke rats.
Zhang H; Wang L; Zhu B; Yang Y; Cai C; Wang X; Deng L; He B; Cui Y; Zhou W
Eur J Pharmacol; 2023 Jul; 951():175801. PubMed ID: 37207969
[TBL] [Abstract][Full Text] [Related]
3. Novel brain-targeting 3-n-butylphthalide prodrugs for ischemic stroke treatment.
Xiang H; Zhang Q; Han Y; Yang L; Zhang Y; Liu Q; Zhang Z; Zhang L
J Control Release; 2021 Jul; 335():498-514. PubMed ID: 34087248
[TBL] [Abstract][Full Text] [Related]
4. Dl-3-n-butylphthalide improves stroke outcomes after focal ischemic stroke in mouse model by inhibiting the pyroptosis-regulated cell death and ameliorating neuroinflammation.
Ge M; Jin L; Cui C; Han Y; Li H; Gao X; Li G; Yu H; Zhang B
Eur J Pharmacol; 2024 Jul; 974():176593. PubMed ID: 38636800
[TBL] [Abstract][Full Text] [Related]
5. Rapid and improved oral absorption of N-butylphthalide by sodium cholate-appended liposomes for efficient ischemic stroke therapy.
Zhang A; Li J; Wang S; Xu Y; Li Q; Wu Z; Wang C; Meng H; Zhang J
Drug Deliv; 2021 Dec; 28(1):2469-2479. PubMed ID: 34766542
[TBL] [Abstract][Full Text] [Related]
6. Protective multi‑target effects of DL‑3‑n‑butylphthalide combined with 3‑methyl‑1‑phenyl‑2‑pyrazolin‑5‑one in mice with ischemic stroke.
Guan Y; Li P; Liu Y; Guo L; Wu Q; Cheng Y
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34643246
[TBL] [Abstract][Full Text] [Related]
7. Dl-3-N-Butylphthalide Alleviates the Blood-Brain Barrier Permeability of Focal Cerebral Ischemia Reperfusion in Mice.
Li J; Liu Y; Zhang X; Chen R; Zhang L; Xue J; Gao X
Neuroscience; 2019 Aug; 413():99-107. PubMed ID: 31247236
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effects and molecular mechanisms of DL-3-n-butylphthalide combined with dual antiplatelet therapy in acute ischemic stroke.
Du Y; Li L; Li X; Tan J; Qin Y; Lv Y; Zhai X
Int Immunopharmacol; 2024 Mar; 129():111592. PubMed ID: 38295546
[TBL] [Abstract][Full Text] [Related]
9. Reactive Oxygen Species-Responsive Transformable and Triple-Targeting Butylphthalide Nanotherapy for Precision Treatment of Ischemic Stroke by Normalizing the Pathological Microenvironment.
Yang Q; Pu W; Hu K; Hu Y; Feng Z; Cai J; Li C; Li L; Zhou Z; Zhang J
ACS Nano; 2023 Mar; 17(5):4813-4833. PubMed ID: 36802489
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of hybrids from optically active ring-opened 3-N-butylphthalide derivatives and 4-fluro-edaravone as potential anti-acute ischemic stroke agents.
Jia J; Wu J; Ji D; Jiao W; Wang X; Huang Z; Zhang Y
Bioorg Med Chem; 2022 Sep; 69():116891. PubMed ID: 35764031
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological Characterization of a Novel Neuroactive Steroid Prodrug, NTS-104, and Its Neuroprotective Activity in Experimental Stroke Models.
Zhang L; Schwartz-Byrne R; Gertz S; McGuire M; Woodhouse C; Powell B; Wei M; Li C; Billing CB; Verdoorn TA; Lam L; Parry TJ; Buller B; Zhang ZG; Poulsen D; Chopp M
Stroke; 2022 Nov; 53(11):3455-3464. PubMed ID: 36168130
[TBL] [Abstract][Full Text] [Related]
12. Improvement of cerebral ischemia-reperfusion injury by L-3-n-butylphthalide through promoting angiogenesis.
Huang Y; Pan L; Wu T
Exp Brain Res; 2021 Jan; 239(1):341-350. PubMed ID: 33180154
[TBL] [Abstract][Full Text] [Related]
13. L-3-n-Butylphthalide reduces ischemic stroke injury and increases M2 microglial polarization.
Li F; Ma Q; Zhao H; Wang R; Tao Z; Fan Z; Zhang S; Li G; Luo Y
Metab Brain Dis; 2018 Dec; 33(6):1995-2003. PubMed ID: 30117100
[TBL] [Abstract][Full Text] [Related]
14. Novel 2,6-disubstituted benzofuran-3-one analogues improve cerebral ischemia/reperfusion injury via neuroprotective and antioxidative effects.
Yang Z; Luo G; Ying Y; Li H; Wan Y; Xu G; Li M; Xian Y; Feng Y; Fang Y
Bioorg Chem; 2023 Mar; 132():106346. PubMed ID: 36638655
[TBL] [Abstract][Full Text] [Related]
15.
Li G; Ruan L; Meng H; Liu W; Zhong X; Yu J; Zhang L; Zhu M; Wang J
Neurochem Res; 2022 Oct; 47(10):3024-3036. PubMed ID: 35737204
[TBL] [Abstract][Full Text] [Related]
16. 2-(1-Hydroxypentyl)-benzoate increases cerebral blood flow and reduces infarct volume in rats model of transient focal cerebral ischemia.
Zhang Y; Wang L; Li J; Wang XL
J Pharmacol Exp Ther; 2006 Jun; 317(3):973-9. PubMed ID: 16527903
[TBL] [Abstract][Full Text] [Related]
17. Dl-3-n-butylphthalide attenuates cerebral ischemia/reperfusion injury in mice through AMPK-mediated mitochondrial fusion.
Zhu T; Dong S; Qin N; Liu R; Shi L; Wan Q
Front Pharmacol; 2024; 15():1357953. PubMed ID: 38455957
[No Abstract] [Full Text] [Related]
18. L-3-n-butylphthalide improves cognitive deficits in rats with chronic cerebral ischemia.
Xu J; Wang Y; Li N; Xu L; Yang H; Yang Z
Neuropharmacology; 2012 Jun; 62(7):2424-9. PubMed ID: 22386716
[TBL] [Abstract][Full Text] [Related]
19. The protective effect and its mechanism of 3-n-butylphthalide pretreatment on cerebral ischemia reperfusion injury in rats.
Yan RY; Wang SJ; Yao GT; Liu ZG; Xiao N
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5275-5282. PubMed ID: 29228445
[TBL] [Abstract][Full Text] [Related]
20. Dl-3-n-butylphthalide inhibits neuroinflammation by stimulating foxp3 and Ki-67 in an ischemic stroke model.
Liu X; Liu R; Fu D; Wu H; Zhao X; Sun Y; Wang M; Pu X
Aging (Albany NY); 2021 Jan; 13(3):3763-3778. PubMed ID: 33461169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
